Portage Biotech Inc (NAS:PRTG)
$ 0.4999 0.2219 (86.34%) Market Cap: 9.89 Mil Enterprise Value: 4.82 Mil PE Ratio: 0 PB Ratio: 0.31 GF Score: 30/100

Portage Biotech Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript

Sep 21, 2021 / 01:05PM GMT
Release Date Price: $19.74 (+6.24%)
Kevin DeGeeter
Oppenheimer & Co. - Analyst

Alright. I want to thank everyone for joining us this morning. The next presenting company, Portage Biotech, really a company we're very excited about. Presenting will be the company's CEO, Ian Walters. Ian, over to you.

Ian Walters
Portage Biotech Inc - CEO & Director

Thank you, Kevin, I really appreciate the opportunity to introduce Portage to everybody today. Good morning. For those of you not familiar, we are an immuno-oncology company and our goal really is to try to advance the field, get more patients into response and with a good quality of life at the same time.

So the Company really was started by a bunch of pioneers in the space. Many of us were at BMS and developed the leading drugs in this area. We are not a discovery company. We work and partner with other entrepreneurs and small biotechs and academics to access interesting technologies, technologies that we take over the development of. And we have built an efficient model to accelerate these products into the clinic and to human

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot